TBPH Theravance Biopharma, Inc.
Nasdaq · SEC CIK 1583107 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $9.84M 9 sales by 3 insiders
- Filings on record
- 227 since 2021-08-24, latest 2026-09-24 20:37
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Samaha Eli | 10% | — | $5.91M |
| BROSHY ERAN | Dir | — | $2.47M |
| Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | — | $1.46M |
| Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | — | — |
| Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | — | — |
| Sawaf Aziz | SVP, CFO | — | — |
| GRAY SUSANNAH | Dir | — | — |
| O'Connor Donal | Dir | — | — |
| Smaldone Alsup Laurie | Dir | — | — |
| Winningham Rick E | CEO, Dir | — | — |
Transactions 240
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-24 | 2022-05-20 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $8.74 | -2,200 | 331.1K | -0.7% | -$19.2K | |
| 2022-05-24 | 2022-05-20 | TBPH | GRAHAM RICHARD A | SVP, DEVELOPMENT | F - Tax | $8.74 | -3,947 | 384.7K | -1% | -$34.5K | |
| 2022-05-24 | 2022-05-20 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $8.74 | -11.0K | 1.44M | -0.8% | -$96.4K | |
| 2022-05-24 | 2022-05-20 | TBPH | Hindman Andrew A. | SVP, CFO | F - Tax | $8.74 | -3,365 | 479.2K | -0.7% | -$29.4K | |
| D | 2022-04-28 | 2022-04-26 | TBPH | O'Connor Donal | Dir | A - Grant | $0.00 | +9,852 | 53.9K | +22% | $0 |
| D | 2022-04-28 | 2022-04-26 | TBPH | MITCHELL DEAN J | Dir | A - Grant | $0.00 | +9,852 | 60.9K | +19% | $0 |
| D | 2022-04-28 | 2022-04-26 | TBPH | YOUNG WILLIAM D | Dir | A - Grant | $0.00 | +9,852 | 78.0K | +14% | $0 |
| D | 2022-04-28 | 2022-04-26 | TBPH | MALKIEL BURTON G | Dir | A - Grant | $0.00 | +9,852 | 91.5K | +12% | $0 |
| D | 2022-04-28 | 2022-04-26 | TBPH | Smaldone Alsup Laurie | Dir | A - Grant | $0.00 | +9,852 | 44.7K | +28% | $0 |
| D | 2022-04-28 | 2022-04-26 | TBPH | BROSHY ERAN | Dir | A - Grant | $0.00 | +9,852 | 60.9K | +19% | $0 |
| D | 2022-04-28 | 2022-04-26 | TBPH | PAKIANATHAN DEEPIKA | Dir | A - Grant | $0.00 | +9,852 | 27.7K | +55% | $0 |
| 2022-03-02 | 2022-02-28 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $10.16 | -2,356 | 333.3K | -0.7% | -$23.9K | |
| D | 2022-03-01 | 2022-02-25 | TBPH | Winningham Rick E | CEO, Dir | A - Grant | $0.00 | +170.0K | 1.45M | +13% | $0 |
| 2022-02-23 | 2022-02-18 | TBPH | Hindman Andrew A. | SVP, CFO | F - Tax | $9.61 | -26.0K | 481.3K | -5% | -$249.6K | |
| 2022-02-23 | 2022-02-18 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $9.61 | -22.7K | 1.28M | -2% | -$218.2K | |
| 2022-02-23 | 2022-02-18 | TBPH | PITZER KENNETH R | SVP, PROD STRAT, COMM PLNG | F - Tax | $9.61 | -27.3K | 380.1K | -7% | -$262.3K | |
| 2022-02-23 | 2022-02-18 | TBPH | GRAHAM RICHARD A | SVP, DEVELOPMENT | F - Tax | $9.61 | -20.4K | 388.7K | -5% | -$195.8K | |
| 2022-02-23 | 2022-02-18 | TBPH | BRADY ANN | Pres, TBIL | F - Tax | $9.61 | -8,369 | 110.3K | -7% | -$80.4K | |
| 2022-02-23 | 2022-02-18 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.61 | -11.8K | 335.6K | -3% | -$113.6K | |
| 2022-02-09 | 2022-02-07 | TBPH | PITZER KENNETH R | SVP, PROD STRAT, COMM PLNG | A - Grant | $0.00 | +52.0K | 407.4K | +15% | $0 | |
| 2021-12-16 | 2021-12-14 | TBPH | SVP, Comm, Medical Affairs | A - Grant | $0.00 | +27.5K | 347.5K | +9% | $0 | ||
| 2021-12-06 | 2021-12-02 | TBPH | Hindman Andrew A. | SVP, CFO | A - Grant | $0.00 | +340.0K | 507.3K | +203% | $0 | |
| 2021-12-06 | 2021-12-02 | TBPH | GRAHAM RICHARD A | SVP, Development | A - Grant | $0.00 | +240.0K | 409.1K | +142% | $0 | |
| 2021-11-23 | 2021-11-19 | TBPH | BRADY ANN | Pres, TBIL | F - Tax | $8.36 | -3,169 | 118.7K | -3% | -$26.5K | |
| 2021-11-23 | 2021-11-19 | TBPH | Hindman Andrew A. | SVP, CFO | F - Tax | $8.36 | -1,350 | 167.3K | -0.8% | -$11.3K | |
| 2021-11-23 | 2021-11-19 | TBPH | PASQUALONE FRANK | SVP, Chief BUSINESS Off | F - Tax | $8.36 | -3,779 | 429.8K | -0.9% | -$31.6K | |
| 2021-11-23 | 2021-11-19 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $8.36 | -11.4K | 1.30M | -0.9% | -$95.3K | |
| 2021-11-23 | 2021-11-19 | TBPH | PITZER KENNETH R | SVP, PROD STRAT, COMM PLNG | F - Tax | $8.36 | -4,310 | 355.4K | -1% | -$36.0K | |
| 2021-11-23 | 2021-11-19 | TBPH | WORBOYS PHILIP D | SVP, RESEARCH, TRANSL SCIENCE | F - Tax | $8.36 | -4,310 | 330.8K | -1% | -$36.0K | |
| 2021-11-23 | 2021-11-19 | TBPH | SABESAN VIJAY | SVP, TECHNICAL Ops | F - Tax | $8.36 | -5,191 | 235.5K | -2% | -$43.4K | |
| 2021-11-23 | 2021-11-19 | TBPH | GRAHAM RICHARD A | SVP, DEVELOPMENT | F - Tax | $8.36 | -4,263 | 169.1K | -2% | -$35.6K | |
| 2021-08-24 | 2021-08-20 | TBPH | BRADY ANN | Pres, TBIL | F - Tax | $14.05 | -3,169 | 121.9K | -3% | -$44.5K | |
| 2021-08-24 | 2021-08-20 | TBPH | Shafer Bradford J | EVP, Gen. Counsel, Sec | F - Tax | $14.05 | -4,307 | 277.8K | -2% | -$60.5K | |
| 2021-08-24 | 2021-08-20 | TBPH | PASQUALONE FRANK | SVP, Chief Business Off | F - Tax | $14.05 | -3,779 | 433.6K | -0.9% | -$53.1K | |
| 2021-08-24 | 2021-08-20 | TBPH | PITZER KENNETH R | SVP, Prod Strat, Comm Plng | F - Tax | $14.05 | -4,307 | 359.7K | -1% | -$60.5K | |
| 2021-08-24 | 2021-08-20 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $14.05 | -11.4K | 1.31M | -0.9% | -$160.2K | |
| 2021-08-24 | 2021-08-20 | TBPH | WORBOYS PHILIP D | SVP, Research, Transl Science | F - Tax | $14.05 | -4,307 | 335.1K | -1% | -$60.5K | |
| 2021-08-24 | 2021-08-20 | TBPH | SABESAN VIJAY | SVP, Technical Ops | F - Tax | $14.05 | -5,193 | 240.7K | -2% | -$73.0K | |
| 2021-08-24 | 2021-08-20 | TBPH | Hindman Andrew A. | SVP, CFO | F - Tax | $14.05 | -17.5K | 167.4K | -9% | -$245.4K | |
| 2021-08-24 | 2021-08-20 | TBPH | GRAHAM RICHARD A | SVP, Development | F - Tax | $14.05 | -6,819 | 173.2K | -4% | -$95.8K |
Purchase Sale Sale after option exercise All abbreviations